December 2nd 2021 11:00 am EST
Overcoming challenges in cell and gene therapy trials and patient access
Loading...
A discussion on how real world data and patient involvement can boost outcomes
Advancements in cell and gene therapies offer an unprecedented level of hope for patients, but present essential differences from the experience with conventional medicines. These unique challenges exist across multiple aspects of the patient journey, from clinical trial recruitment to long-term follow-up, including access to these transformative therapies.
Join patient advocates and industry experts as they share their experiences, challenges and potential solutions in this upcoming panel from VOZ Advisors and Clarivate.
Join patient advocates and industry experts as they share their experiences, challenges and potential solutions in this upcoming panel from VOZ Advisors and Clarivate.
We will be covering the following topics:
-
Understand key concerns and needs of patients and families in clinical trials, including undergoing the informed consent process, navigating trial participation and accessing their data and results
-
Address challenging access and reimbursement issues to ensure patients can take advantage of these transformative treatments
-
Harness real-world evidence and other data sources to optimize R&D and regulatory initiatives, and improve the patient experience
Panelists:
Mike Ward
Head of Thought Leadership, Life Sciences & Healthcare, Clarivate
Alison Bateman-House
Assistant Professor of Medical Ethics, NYU Grossman School of Medicine
Christeen Moburg
Vice President of Patient Advocacy & Government Relations, Sangamo Therapeutics
Kim Stephens
President, Project Alive
Simon Andrews
Vice President, RWD Engagements and Innovation, Clarivate
Tim Turnham
Vice President of Client
Services, VOZ Advisors
Services, VOZ Advisors